HMO External Review Rights

Authority Network America›Life Services Authority›National Health Insurance Authority›HMO Authority

HMO External Review Rights

When an HMO denies a claim or refuses to authorize a medical service, enrollees have the right to challenge that decision through an independent review process conducted outside the health plan. External review rights establish a formal mechanism by which a neutral third party — not the insurer — renders a binding determination on whether a denial was medically appropriate or contractually proper. This page covers the legal framework governing external review, the procedural steps involved, the types of disputes eligible for review, and the boundaries of what an external reviewer can and cannot decide.

Definition and scope

External review is a statutory right that allows HMO enrollees to submit a disputed coverage denial to an Independent Review Organization (IRO) that has no financial relationship with the plan. The Affordable Care Act (ACA) established a federal floor for external review rights through Section 2719 of the Public Health Service Act, codified at 45 C.F.R. § 147.107. Under that framework, all non-grandfathered health plans — including HMOs offered through employers and the individual market — must provide access to external review that meets either the applicable state standard or the federal standard administered by the Department of Health and Human Services (HHS).

The scope of external review covers two primary categories of denial:

• Adverse benefit determinations — denials, reductions, or terminations of covered benefits, including failures to provide a timely authorization decision.
• Final internal appeals decisions — denials that have been upheld after the plan's own internal appeals process is exhausted (or after 4 months from the date of the adverse determination in certain circumstances).

State law governs external review for fully insured HMO plans, while federal law under ERISA applies to self-funded employer plans. A detailed breakdown of how ERISA interacts with HMO coverage rules appears at /erisa-and-hmo-plans. Enrollees should also review hmo-consumer-protections-and-grievance-procedures to understand how external review fits within the broader grievance framework.

How it works

The external review process follows a structured sequence once internal appeals are exhausted or deemed waived.

• Eligibility screening — The plan or the relevant state agency confirms the denial qualifies for external review. Excluded disputes typically include claims involving non-covered benefits (e.g., a service explicitly excluded by the plan contract) or disputes based solely on plan eligibility.
• IRO assignment — A certified Independent Review Organization is randomly assigned. The IRO must be accredited by URAC or a comparable accreditation body and may not have a material conflict of interest with the plan or enrollee.
• Record submission — The HMO transmits the complete claim file, including medical records, the denial rationale, and any clinical guidelines used to justify the decision, promptly of the IRO assignment for standard reviews (45 C.F.R. § 147.107(b)(2)).
• Expedited track — For urgent or concurrent care denials involving a serious medical condition, expedited external review must be completed within 72 hours of a request, compared to the standard 45-day timeline.
• IRO decision — The IRO issues a written decision with clinical rationale. That decision is binding on the health plan; the plan must authorize or pay the disputed service if the IRO rules in the enrollee's favor.

The key procedural contrast between standard external review and expedited external review lies in timing and eligibility: standard review applies to retrospective denials and post-treatment billing disputes, while expedited review is reserved for situations where the standard timeline would seriously jeopardize life, health, or the ability to regain maximum function (CMS guidance on external review).

Common scenarios

External review most frequently arises in four categories of HMO dispute:

• Medical necessity denials — The plan determines a requested service (surgery, inpatient stay, specialty drug) is not medically necessary. The IRO reviews clinical evidence against recognized medical standards to determine whether the plan's criteria were appropriately applied.
• Experimental or investigational treatment denials — HMOs routinely deny treatments classified as experimental. External reviewers evaluate published clinical evidence, FDA approval status, and consensus guidelines from bodies such as the National Comprehensive Cancer Network (NCCN).
• Referral and specialist access disputes — Denials linked to the referral process, particularly for out-of-network specialists when no adequate in-network provider exists, may qualify. The mechanics of referral disputes are detailed at how-hmo-referrals-work.
• Concurrent care terminations — Abrupt termination of an ongoing course of treatment triggers expedited review eligibility under both state and federal standards.

Disputes involving only administrative errors (billing code mismatches with no clinical component) or contract interpretation questions unrelated to medical necessity generally fall outside the IRO's jurisdiction and require separate legal channels.

Decision boundaries

External reviewers operate within defined jurisdictional limits. An IRO evaluates only whether the plan's denial was consistent with the terms of the plan document, applicable medical evidence, and accepted clinical standards. It cannot:

• Expand coverage to services explicitly excluded by the plan contract (e.g., cosmetic procedures carved out entirely)
• Override plan eligibility determinations (enrollment disputes remain with the plan and regulatory agencies)
• Award damages, penalties, or attorney's fees — the remedy is limited to requiring the plan to cover the disputed service
• Reopen claims that were not first submitted through the plan's internal appeals process, except where the plan waived or failed to provide internal appeals

State-specific rules may expand these boundaries. As of the NAIC's 2023 model act updates, 46 states and the District of Columbia have external review laws that meet or exceed the federal standard (National Association of Insurance Commissioners, External Review Model Act). States such as California, New York, and Texas maintain independent state IRO programs with timelines and eligibility rules that differ from the federal default.

For a broader orientation to HMO plan rights and structures, the HMO authority homepage provides an organized entry point to related coverage topics.

References

• Authority Network America
• Life Services Authority
• National Health Insurance Authority
• 45 C.F.R. § 147.107
• CMS guidance on external review
• National Association of Insurance Commissioners, External Review Model Act

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)